Stay updated on Psilocybin for Alcohol Use Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.

Latest updates to the Psilocybin for Alcohol Use Disorder Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record view. The site header and footer remain visible, but access to the study content is blocked.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record. This blocks access to the core content and associated trial details on the page.SummaryDifference20%

- Check45 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, representing a new revision of the page.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows a new revision number, updating from v3.6.4 to v3.6.5, indicating a minor update to the page’s underlying systems or documentation. This update does not appear to modify the study content or displayed data.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now includes updated study metadata: the site is listed as Psychiatric Centre Rigshospitalet, and the principal investigator is Anders Fink-Jensen, MD, DMSci, with the verification date noted as 2024-07 and the last verified status listed as Unknown. These details clarify who is responsible for the study and where it is conducted.SummaryDifference0.5%

Stay in the know with updates to Psilocybin for Alcohol Use Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.